The clinical utility of inhibiting CD28-mediated costimulation
Article first published online: 21 APR 2009
© 2009 Bristol-Myers Squibb Company
Special Issue: Mechanisms of Costimulation
Volume 229, Issue 1, pages 307–321, May 2009
How to Cite
Linsley, P. S. and Nadler, S. G. (2009), The clinical utility of inhibiting CD28-mediated costimulation. Immunological Reviews, 229: 307–321. doi: 10.1111/j.1600-065X.2009.00780.x
- Issue published online: 21 APR 2009
- Article first published online: 21 APR 2009
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.